Buy
Sell
Share Name Share Symbol Market Type Share ISIN Share Description
Ideagen Plc LSE:IDEA London Ordinary Share GB00B0CM0C50 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  2.50 0.91% 278.50 275.00 282.00 278.50 278.50 278.50 56,544 08:00:00
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Software & Computer Services 56.6 -0.1 -0.1 - 703

Ideagen Share Discussion Threads

Showing 1526 to 1550 of 1750 messages
Chat Pages: 70  69  68  67  66  65  64  63  62  61  60  59  Older
DateSubjectAuthorDiscuss
14/1/2019
08:09
Yes looking good rivaldo,,,,,,IDEA has done it again :-)
cheshire man
14/1/2019
07:42
Good-looking acquisition today for £3.5m - earnings-enhancing for the coming financial year, lots of recurring revenues, and in the fast-growing Environmental sector: Https://www.investegate.co.uk/ideagen-plc--idea-/rns/acquisition-of-scannell-solutions-ltd/201901140700059403M/ Plus lots of great clients which will aid cross-selling to the likes of "100 customers including Intel, Johnson and Johnson, BT, Heineken and Coca Cola".
rivaldo
11/1/2019
12:55
Jim - in a massive sell off, I am sure you are right. However I was comforted by this comment from the last TU in Nov. Given the momentum of our SaaS business the Company now expects to generate 74% of its revenues from recurring contracts by the end of 2020, up from the 70% previously anticipated. I can think of many other stocks that might be affected more severely than IDEA - even in a recession companies have to look after their Governance, Risk and Compliance.
melody9999
10/1/2019
08:19
I have sold 3/4 of my holdings in IDEA. This is a reaction to the overall market situation. IDEA is still a great company but if the market has a massive sell off, it will follow.
jimbobaroony
09/1/2019
10:17
leavers - I am! having reduced my holding during the pullback, I have just reviewed all the IDEA activity in the past year - and boy have they been busy. Some of it here hxxps://www.ideagen.com/company/news Feels like a business firing on all cylinders and I expect this to be reflected in the HY which I have as 26 jan (though this may be last years date) But not long to wait. GLAH
melody9999
08/1/2019
20:55
Pretty savage pull back from the 170 high. There was certainly a lot of bullishness at that time on advfn without any reference to the valuation the company was trading at - the shares were way over-stretched by every metric. Who's a buyer now?
leavers
28/12/2018
13:48
hxxps://www.stockopedia.com/content/small-cap-value-report-fri-28-dec-2018-idea-placeholder-430673/ Small Cap Value Report (Fri 28 Dec 2018) - IDEA, placeholder positive.
petewy
06/12/2018
09:25
Hmmm.................had better days
soundbuy
28/11/2018
09:17
This sounds good - and the roll-out still has a long way to go, with only 8 out of 35 subsidiaries completed to date: Http://www.einnews.com/pr_news/469075236/ideagen-s-software-helps-ratp-dev-usa-reduce-vehicle-accidents-by-19 "Ideagen’s software helps RATP Dev USA ‘reduce vehicle accidents by 19%’ The safety stats were unveiled at the global transportation leader’s recent Safety Summit in Texas NOTTINGHAM, UNITED KINGDOM, November 26, 2018 /EINPresswire.com/ -- Ideagen, the UK-based, global software firm, today announced it has helped a major transportation company reduce vehicle accidents by 19%. RATP Dev USA, a wholly owned subsidiary of RATP Group which operates and maintains urban intercity transportation systems in 14 countries, launched its ‘drive2zero™’ Safety Management System (SMS) last year and adopted Ideagen’s software. Coruson, Ideagen’s cloud-based system for enterprise safety, quality, reporting and incident management, is used by RATP Dev USA to directly manage safety, risk and operational performance across all bus, paratransit and rail services. Mike Anderson, VP of Safety and Security for RATP Dev USA, said: “We started implementing SMS in our subsidiaries back in December 2017 and, to date, we’ve implemented SMS in eight out of around 35 - so we still have a lot of work to do. “But our initial results are very promising – we’ve seen an overall reduction year-to-date of 19% in vehicle accidents alone.”.... .....RATP Dev USA transports more than 78 million passengers across the United States through various transportation services such as bus, urban or intercity rail lines (streetcar), and shuttle services. etc"
rivaldo
23/11/2018
11:00
Yes very reassuring Rivaldo, to see Liontrust adding heavily. Just checking in from a break in Belfast, another one to tick off the bucket list.
igoe104
22/11/2018
12:24
Liontrust are really piling in here - another RNS just out. They now own 15.33%, or 33.6m shares. That's over 5m more shares bought in the last few days: Https://www.investegate.co.uk/ideagen-plc--idea-/rns/holding-s--in-company/201811221212062354I/
rivaldo
21/11/2018
17:19
Here is your chance to meet with Ideagen: Using this unique discount code, ADVFN25, you will be able to get £25 off at Mello London 2018, a 2 day investor conference from the 26th – 27th November 2018 at the Clayton Hotel, Chiswick, London. Http://melloevents.com/mello-london/ Tickets are normally priced at £99 for two days and £79 for one. Type in ADVFN25 as the discount code. Many Thanks and take advantage of this premium offer. See you there.
advfn_sales
21/11/2018
09:39
His results today for LIO were good. (Long term holder)
petewy
21/11/2018
09:38
Good to see :-)
cheshire man
21/11/2018
09:26
Anthony Cross at Liontrust is a top fundmanager and knows Ideagen very well having invested at 19p in 2013...his conviction is a real positive
themachine99
20/11/2018
13:55
RNS - Liontrust continue to buy. They've now got 12.88%, or 28.2m shares. A month ago they had 24.6m shares, so they've added a nice 3.6m shares since then: Https://www.investegate.co.uk/ideagen-plc/rns/holding-s--in-company/201811201204149246H/
rivaldo
18/11/2018
21:02
Here is the full two day programme schedule for MelloLondon including Ideagen Http://melloevents.com/wp-content/uploads/2018/11/MT16.11v2.pdf It is jam packed full of about 75 company presentations, lots of top quality speakers and panel sessions plus workshops to help with investment style and techniques etc. The pre event fun starts on the Sunday evening with a dinner and investor quiz hosted by John Lee but the main conference begins on Monday 26th November at 9am through to Tuesday 27th in the evening so do come and join us as there are still 97 tickets left... Http://melloevents.com/mello-london/ See you there.
davidosh
13/11/2018
16:32
Surprised at the selling but in these markets a bird in the hand and all that.....one that is staying in my PF,,,,,,,excellent update this morning IMO :-)
cheshire man
13/11/2018
14:27
Hmmmm........expected a tad better..........soggy market.....zzzz
soundbuy
13/11/2018
12:55
just tried a dummy trade 2000 shares offered at 146.273, just above the bid price and same price as the last sell trade!
jonut
13/11/2018
09:57
buys showing up as sells
petewy
13/11/2018
09:32
Finncap retain their 180p target: Http://investing.thisismoney.co.uk/broker-views/
rivaldo
13/11/2018
07:41
Agreed. Wonderful recurring income, and a very strong H1 update: "The Board is pleased to report that trading has remained strong in the first half of the financial year and that revenue and EBITDA are both expected to be significantly ahead of the same period last year and in line with management's expectations." Cash generation remains strong, so it's still possible we'll get more acquisitions this year. And confidence remains high: "The market opportunity remains large and long term and given the Group's position as a leader in the Governance, Risk and Compliance market, the Board is optimistic about the Group's continued growth prospects."
rivaldo
13/11/2018
07:27
'the Company now expects to generate 74% of its revenues from recurring contracts by the end of 2020, up from the 70% previously anticipated' .......this I like............
soundbuy
13/11/2018
07:21
RNS Number : 1155H Ideagen PLC 13 November 2018 Trading Update Ideagen PLC (AIM: IDEA), a leading supplier of Information Management Software to highly regulated industries, today provides an update on trading for the six months ended 31 October 2018. The Board is pleased to report that trading has remained strong in the first half of the financial year and that revenue and EBITDA are both expected to be significantly ahead of the same period last year and in line with management's expectations. This has been achieved through both organic revenue growth and the acquisitions of Medforce (acquired in April), InspectionXpert and MK Insight (both acquired in September) The Company has a clear strategy to grow revenues organically and maintain high EBITDA margins whilst transitioning from a perpetual licence to a SaaS based subscription model. The successful execution of this strategy will provide an even more robust business model and provide a higher quality of earnings over the medium term without impacting the short-term profitability of the business. Historically the board has measured performance using a number of KPIs such as total revenue growth, organic revenue growth, EBITDA and EPS growth. The board will now also report total bookings growth and SaaS booking growth which are both important metrics during the transition period and beyond. Strong customer demand and sales execution in the period indicates that the transition is progressing successfully and is ahead of schedule. Total like for like bookings growth increased by 34% and total like for like SaaS bookings increased by 80%. Given the momentum of our SaaS business the Company now expects to generate 74% of its revenues from recurring contracts by the end of 2020, up from the 70% previously anticipated. Organic revenue growth in the period was 8% which, in the context of an accelerated SaaS transition, represents a strong performance. The Company continues to compete and win new business within the UK and international markets reflecting the Company's global expansion. During the period the Company won 120 new customer logos including GlaxoSmithKline, Boston Biomedical, Virginia State Office, McLaren, Mercedes AMG, Keolis and Cancer Research. At the period end the group had net debt of GBP1.3 million (30 April 2018: net cash of GBP0.8 million) after spending GBP24.3 million on acquisitions and raising GBP19.4 million net of costs on a share placing. Operating cash generation in the period remained strong. Ben Dorks, Chief Executive Officer of Ideagen, commented: "I am pleased to report another excellent start to Ideagen's financial year. Our core markets are strong and underpin the demand we have seen this half. We continue to execute our strategy, delivering growth and investing in the business whilst tightly managing the cost base. The Company has continued to make acquisitions which have further enhanced our global reach, customer base and product capability. Cash generation has been robust which coupled with further growth in new SAAS recurring revenues and an increase in repeat business from our growing customer base provides a strong platform for the second half The market opportunity remains large and long term and given the Group's position as a leader in the Governance, Risk and Compliance market, the Board is optimistic about the Group's continued growth prospects."
multibagger
Chat Pages: 70  69  68  67  66  65  64  63  62  61  60  59  Older
ADVFN Advertorial
Your Recent History
LSE
IDEA
Ideagen
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20210518 09:33:22